In the country, the study is described as one of the most sophisticated research projects in the COVID-19 context. 

In India, the first animal study on Coronavirus that is a collaborative effort between the Department of Biotechnology and the Ministry of Ayush, Government of India, has progressed to its final stage. 

The Ministry of Ayush stated that this includes a pre-clinical study on four oral interventions that have been already set for clinical studies. 

The clinical studies are being followed via another Ministry of Ayush collaboration, in this, the partner is the Council for Scientific and Industrial Research (CSIR). 

The animal study-related collaboration (in-vivo) arose from an MoU signed between the Ministry of Ayush, National Medicinal Plants Board (NMPB), and the DBT). 

It is based on reverse Pharmacology (PH) concept which discovers the scientific reasoning behind settled medical practice such as those of Ayurveda, the statement said. 

The study is being progressed at the Translational Health Science and Technology Institute (THSTI), which is an autonomous institution of DBT based in Faridabad. 

THSTI BSL-3 level laboratories were housing animal studies, being held on hamsters. 

Ayush Ministry Secretary Vaidya Rajesh Kotecha shared that “this is a proud moment for both, the Ministry of Ayush and the Department of Biotechnology that this wonderful collaboration is moving to a landmark research in the country.” 

Share this :